Thomas J. Herzfeld Advisors’s Celgene Corp CELG Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-300	Closed	-$28K	–	314
2019 Q1	$28K	Hold	300	–	–	0.01%	202
2018 Q4	$19K	Hold	300	–	–	0.01%	212
2018 Q3	$27K	Hold	300	–	–	0.01%	192
2018 Q2	$24K	Hold	300	–	–	0.01%	211
2018 Q1	$27K	Hold	300	–	–	0.01%	218
2017 Q4	$31K	Sell	300 -500	-63%	-$56.4K	0.01%	205
2017 Q3	$117K	Hold	800	–	–	0.05%	134
2017 Q2	$104K	Hold	800	–	–	0.05%	144
2017 Q1	$100K	Hold	800	–	–	0.04%	162
2016 Q4	$93K	Hold	800	–	–	0.04%	164
2016 Q3	$84K	Hold	800	–	–	0.04%	154
2016 Q2	$79K	Hold	800	–	–	0.04%	173
2016 Q1	$80K	Hold	800	–	–	0.04%	176
2015 Q4	$96K	Hold	800	–	–	0.04%	174
2015 Q3	$87K	Buy	+800	New	+$99.3K	0.04%	166

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Thomas J. Herzfeld Advisors's CELG Position: Q2 2019 in Review

Thomas J. Herzfeld Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 300 shares — an estimated $28K sold.

Thomas J. Herzfeld Advisors first reported a position in CELG in Q3 2015 and held it in 15 quarters. The position peaked at $117K in Q3 2017. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Thomas J. Herzfeld Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Thomas J. Herzfeld Advisors sold 300 Celgene Corp shares in Q2 2019, an estimated $28K.
Thomas J. Herzfeld Advisors first reported a position in Celgene Corp in Q3 2015 and held it in 15 quarters.
Thomas J. Herzfeld Advisors's Celgene Corp position peaked at $117K in Q3 2017.
1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.